Akèy › Neoplazmi myeloproliferatif › Tennessee › Nashville
Etid klinik pou Neoplazmi myeloproliferatif nan Nashville, TN
6 etid pou Neoplazmi myeloproliferatif ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Tennessee Oncology, PLLC - Investigational Drug Services, Nashville
- Tristar BMT, Nashville
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Ap rekriteFaz 2
- Vanderbilt University/Ingram Cancer Center, Nashville
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Tristar Bmt/Tcto, Nashville
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Vanderbilt University Medical Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Nashville
Etid Neoplazmi myeloproliferatif nan lòt vil
- Houston, TX16 etid
- New York City, NY15 etid
- Boston, MA14 etid
- Milwaukee, WI10 etid
- Miami, FL10 etid
- Durham, NC9 etid
- Baldwin Park, CA9 etid
- Seattle, WA9 etid
- Chicago, IL9 etid
- Portland, OR8 etid
- Cleveland, OH8 etid
- Atlanta, GA8 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.